FDA Panel Recommends Emergency Use Vaccines

FDA Panel Recommends Emergency Use Vaccines

An F-D-A panel is recommending emergency use authorization for Pfizer’s and BioNTech’s COVID-19 vaccine. 

The decision clears the way for the FDA to grant emergency approval, paving the way for millions of Americans to get vaccinated to protect themselves from the coronavirus that has spread around the world. 

A vaccine being approved in less than a year after most people first learned of the novel coronavirus is a monumental achievement.  Scientists originally estimated it would take between 18 months and two years to get a vaccine approved. 

The first people to get the vaccine will be health care workers and people most at risk, including patients in long-term senior care facilities.

Leave a Reply

Your email address will not be published. Required fields are marked *